Skip to content

Birmingham Hip Resurfacing (BHR) Study: Implantation of a Hip Resurfacing Endoprosthesis

Prospective, Non-Randomised, Non-Comparative Multicentric Investigation of the Functional and Radiological Result and Subjective Patient Outcome After Implantation of a Hip Resurfacing Endoprosthesis (Birmingham Hip Resurfacing)

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00180206
Enrollment
300
Registered
2005-09-16
Start date
2005-01-31
Completion date
2008-12-31
Last updated
2006-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis

Keywords

Arthritis, Hip, Hip arthroplasty, Hip resurfacing arthroplasty

Brief summary

The purpose of this study is the investigation of the functional and radiological results and subjective patient outcome after the implantation of a hip resurfacing endoprosthesis (Birmingham hip resurfacing).

Detailed description

High volumetric wear of polyethylene was the main factor in periprosthetic bone resorption and failure of historic hip resurfacing prosthesis. Metal-on-metal devices reduce the wear substantially and may solve this problem. The purpose of this study is the investigation of the functional and radiological result and subjective patient outcome after implantation of a hip resurfacing endoprosthesis (Birmingham Hip Resurfacing) during the first two years after surgery.

Interventions

Sponsors

Technische Universität Dresden
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Clinical and radiological signs of coxarthritis * Implantation of a total hip replacement indicated * Informed consent

Exclusion criteria

* Osteoporosis * Tumor * Acute infection * Higher grade congenital dysplasia of the hip * Pregnancy

Design outcomes

Primary

MeasureTime frame
Functional result
Radiological result
Subjective patient outcome

Secondary

MeasureTime frame
Perioperative and postoperative complication rate
Revision rate

Countries

Germany

Contacts

Primary ContactWolf-Christoph Witzleb, MD
Wolf-Christoph.Witzleb@uniklinikum-dresden.de+49 (0)351 4583323

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026